Epilepsy Drugs Market

Epilepsy Drugs Market Size by Drug Class (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13970
  • Published Date: Jan, 2024
  • Pages: 236
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global epilepsy drugs market was valued at USD 10 billion in 2022 and grew at a CAGR of 4% from 2023 to 2032. The market is expected to reach USD 14.80 billion by 2032. The increasing prevalence of epilepsy will drive the growth of the global epilepsy drugs market.

Market Introduction:

Epilepsy drugs are also known as antiepileptic drugs (AEDs). They play a crucial role in managing epilepsy by controlling and preventing seizures. These medications target various mechanisms within the brain to modulate abnormal electrical activity. Phenytoin and carbamazepine, valproic acid and clonazepam, ethosuximide, and levetiracetam are a few examples of epilepsy drugs. Epilepsy drugs stabilize electrical activity in the brain by reducing the frequency and intensity of seizures. The benefits of these medications extend beyond seizure control, encompassing an improved quality of life for individuals with epilepsy. Epilepsy drugs also contribute to psychosocial well-being. Additionally, these drugs play a vital role in preventing complications associated with uncontrolled epilepsy, such as injuries and accidents. The selection of specific drugs is personalized based on the type of seizures and individual patient characteristics.

Epilepsy Drugs Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • By examining behavioural patterns in epileptic mice using cutting-edge technology, scientists may be able to better understand the condition and find new therapies. The National Institutes of Health-funded researchers employed A.I. technology to identify mouse behavioural "fingerprints" that are invisible to the naked eye. Researchers did not have to wait for the extremely unusual occurrence of a seizure in order to conduct automated behavioural phenotyping; only one hour of video recording was necessary. Published in Neuron, the study was funded by the National Institute of Neurological Disorders and Stroke (NINDS), a National Institutes of Health division. Researchers discovered that this machine learning-assisted 3D video analysis performed better than the conventional method, which labels the behavioural indicators of epilepsy in animal models by analyzing the videos based on human observation.

Market Dynamics:

Drivers

The increasing prevalence of epilepsy due to accidents and injuries – The increased occurrences of accidents, sports injuries, and other trauma-related violence have contributed to an increasing incidence of epilepsy. Additionally, increases in infectious diseases, particularly those affecting the central nervous system (CNS), pose another potential risk factor for epilepsy. Outbreaks of CNS infections, like encephalitis or meningitis, can result in inflammation and scarring in the brain, contributing to an elevated risk of developing epilepsy. The rising incidence of infectious diseases on a global scale and increasing incidence of accidents will increase the risk of epilepsy and drive the global epilepsy drugs market’s growth.

Restraints:

The side effects associated with epilepsy drugs Cognitive effects such as memory issues, gastrointestinal distress, dizziness, and mood changes are common side effects of epilepsy drugs. Skin reactions and weight changes are also possible. These side effects can impact daily functioning and quality of life, potentially leading to discontinuation of treatment by many. Therefore, the side effects of epilepsy drugs may limit its adoption, thereby limiting the market's growth.

  • Regarding two commonly used medications for epilepsy, levetiracetam and clobazam, the FDA issued a caution. The medications appear to be connected to Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome, an uncommon but dangerous allergic reaction. Worldwide, reports of over 40 cases of DRESS syndrome—a potentially fatal reaction—in patients taking these medications have been made. 
Opportunities:

Increasing research and development infrastructure the development and approval of new antiepileptic drugs (AEDs) mark the advancements in epilepsy drugs in the recent past. These innovations enhance treatment outcomes by improving efficacy, minimizing side effects, and expanding therapeutic options. These advancements reflect positive strides in epilepsy drug development and will contribute to the global epilepsy drug market's growth and development in the future.

  • The results of a new phase 2b study demonstrate that the innovative medication XEN1101 can safely be administered at its highest dosage and effectively reduces seizures in individuals with treatment-resistant focal epilepsy when added to conventional antiseizure regimens. Researchers evaluated XEN1101's safety, tolerability, and effectiveness compared to a placebo.
Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global epilepsy drugs market, with a 36% market revenue share in 2022.

The North American epilepsy drugs market thrives due to its advanced research and development landscape. It is also home to prominent pharmaceutical companies and research institutions, furthering innovation and research in epilepsy drugs. The robust regulatory environment improves compliance, efficacy and accountability of drugs. High healthcare spending contributes to the market's growth.

North America Region Epilepsy Drugs Market Share in 2022 - 36%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • DCGI approved the formulation of contract manufacturing medication company Akums Drugs & Pharmaceuticals to treat specific types of seizures in epileptic patients. According to a statement from the company, the approval enables Perampanel Oral Suspension to be used as adjunctive therapy for the treatment of primary generalized tonic-clonic (PGTC) seizures and partial-onset seizures (POS) in patients with epilepsy aged 12 years and older in the nation, with or without secondary generalized seizures.
Drug Class Segment Analysis

The drug class segment is divided into first-generation drugs, second-generation drugs, and third-generation drugs. The second-generation drugs segment dominated the market, with a market share of around 44% in 2022. Second-generation epilepsy drugs include Lamotrigine, Levetiracetam, and Topiramate. They offer greater benefits than their older counterparts. Their broader spectrum of activity makes them effective against various seizure types and epilepsy syndromes. These drugs generally present improved side effect profiles with fewer cognitive effects. Convenience in dosing, Reduced drug interactions and a lower likelihood of side effects contribute to their popularity. These drugs provide flexibility and improved tolerability in epilepsy management.

Distributional Channel Segment Analysis

The distribution channel segment is divided into hospital pharmacies, retail pharmacies and online pharmacies. The retail pharmacies segment dominated the market, with a market share of around 45% in 2022. Pharmacies are preferred venues for obtaining epilepsy drugs due to their widespread accessibility and convenience. As trained healthcare professionals, pharmacists provide essential expertise, offering guidance on proper medication usage, potential side effects, and interactions. Additionally, pharmacies maintain adequate stocks of commonly prescribed epilepsy drugs, ensuring availability at all times.

  • Pharmanovia purchased Frisium, an epilepsy medication, from Sanofi. Clobazam, marketed under the name Frisium, is an adjuvant medication used in conjunction with other medications for epilepsy. It is a benzodiazepine, and its mechanism of action is to slow down the brain and body's processes. Global healthcare provider Pharmanovia is based in Basildon, Essex. Pharmanovia went on to say that the packaging will probably be the only alteration made to Frisium's branding.
Some of the Key Market Players:
  • Abbott Laboratories
  • Bausch Health Companies, Inc.
  • GlaxoSmithKline plc
  • H. Lundbeck A/S
  • Johnson & Johnson
  • Novartis AG
  • Sanofi
  • Sumitomo Pharma Co., Ltd.
  • UCB S.A.
  • Viatris Inc.

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 10 Billion
Market size value in 2032 USD 14.80 Billion
CAGR (2023 to 2032) 4%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East and Africa. Furthermore, the regions are further analyzed at the country level.
Segments Drug Class and Distribution Channel

Frequesntly Asked Questions

As per The Brainy Insights, the size of the global epilepsy drugs market was valued at USD 10 billion in 2022 to USD 14.80 billion by 2032.

Global epilepsy drugs market is growing at a CAGR of 4% during the forecast period 2023-2032.

The market's growth will be influenced by the increasing prevalence of epilepsy due to accidents and injuries.

The side effects associated with epilepsy drugs could hamper the market growth.

Request Table of Content

+1

 

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global epilepsy drugs market based on below mentioned segments:

Global Epilepsy Drugs Market by Drug Class:

  • First Generation Drugs
  • Second Generation Drugs
  • Third Generation Drugs

Global Epilepsy Drugs Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Epilepsy Drugs Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date